Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers

伐尼克兰用于青少年非吸烟者戒烟尼古丁的随机对照试验

基本信息

  • 批准号:
    10298337
  • 负责人:
  • 金额:
    $ 66.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT The prevalence of adolescent nicotine vaping is rising more rapidly than any prior known drug. In some areas of the US, over one third of high school seniors vape nicotine regularly. This rapid rise in popularity of electronic nicotine delivery devices (ENDS, “e-cigarettes”, vapes) has reversed five decades of denormalizing youth tobacco use, putting adolescents at high risk for nicotine dependence, tobacco smoking, other drug use, and direct negative health effects of vapor exposure. While sensible regulation raising the purchasing age and eliminating sweet and mint flavors should curb new uptake of adolescent nicotine vaping among never smokers, these policies are causing many to seek vaping cessation treatment. There are an estimated one million adolescents in the US with an addiction to vaped nicotine. No treatment trials for vaping cessation have been published to date to our knowledge. Effective interventions are critical to aid the estimated one million US adolescents now with addiction to vaped nicotine to quit vaping and not start smoking. Varenicline, the most effective known smoking cessation medication, has been well tolerated and associated with significantly higher tobacco abstinence rates and faster time to abstinence in secondary outcomes in two recent small randomized controlled trials in adolescent smokers. In a recent series in our group, varenicline together with text vaping cessation support has been associated with 65% (34 of 52 patients) prolonged vaping abstinence rates (at 3-9 months follow up) in non-smoking adolescents who are dependent on vaped nicotine, while nicotine replacement therapy has been associated with approximately 21% abstinence rates to date in this population. In the current study, we propose to test whether varenicline, the most effective treatment known for nicotine addiction, helps nicotine dependent adolescents to quit vaping nicotine. To do so, we will enroll 300 adolescents, aged 16 - 20, who vape, are nicotine dependent, do not smoke, and want to quit. Adolescents will be recruited through high schools, colleges, and the community in Greater Boston, and those eligible will be enrolled into a double-blind, placebo-controlled, parallel group, intent-to-treat trial of varenicline up to 1 mg bid for 12 weeks added to an active behavioral control intervention involving 12 weeks of text messaging and group behavioral support specifically designed for teen vaping cessation. Medication adherence and trial retention, challenges in prior adolescent smoking cessation trials, will be incentivized and supported with the innovative AiCure smartphone application for remotely directly observed dosing and collection of daily vaping and other data. This proposal is responsive to urgent and growing requests for vaping cessation treatment for adolescents from patients, their families, and schools. Positive results will define an effective treatment that can be used in this rapidly moving epidemic of youth vaping, and will fundamentally change clinical practice.
项目总结/摘要 青少年尼古丁vaping的流行率比任何已知的药物都上升得更快。部分地区 在美国,超过三分之一的高中生经常吸食尼古丁。这种迅速上升的受欢迎程度 电子尼古丁输送装置(ENDS,“电子香烟”,vapes)已经扭转了50年的非正常化 青少年吸烟,使青少年处于尼古丁依赖的高风险,吸烟,其他药物使用, 和直接对健康的负面影响。虽然明智的监管提高了购买年龄, 消除甜味和薄荷味应该抑制青少年尼古丁vaping的新吸收, 吸烟者,这些政策导致许多人寻求戒烟治疗。据估计, 在美国,有100万青少年对尼古丁上瘾。没有治疗试验的vaping停止 据我们所知,迄今已出版。有效的干预措施对于帮助估计100万美国人至关重要。 现在对尼古丁上瘾的青少年应该戒烟,不要开始吸烟。伐尼克兰,最 有效的已知戒烟药物,已被良好耐受,并与显着较高的 在最近两个小型随机研究中, 青少年吸烟者的对照试验。在我们小组最近的一个系列中,varenicline与文本vaping一起 戒烟支持与65%(52例患者中的34例)的长期电子烟戒烟率(3-9 在依赖vaped尼古丁的非吸烟青少年中, 到目前为止,在这一人群中,替代疗法与约21%的戒烟率相关。 在目前的研究中,我们建议测试已知的尼古丁最有效的治疗方法伐尼克兰 成瘾,帮助尼古丁依赖的青少年戒烟尼古丁。为此,我们将招收300名 16 - 20岁的青少年,谁vape,尼古丁依赖,不吸烟,并希望戒烟。青少年将 通过高中,大学和大波士顿的社区招募,那些符合条件的人将被 入组一项双盲、安慰剂对照、平行组、意向治疗试验,伐尼克兰剂量高达1 mg bid 在12周的主动行为控制干预中加入12周的短信, 专门为青少年戒烟而设计的团体行为支持。药物依从性和试验 保留,之前青少年戒烟试验的挑战,将得到激励和支持, 创新的AiCure智能手机应用程序,用于远程直接观察每日vaping的剂量和收集 和其他数据。该提案是对紧急和日益增长的要求vaping停止治疗的回应, 青少年从病人,他们的家庭,和学校。积极的结果将定义一种有效的治疗方法, 可以用于这种快速移动的年轻人vaping流行病,并将从根本上改变临床实践。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

A EDEN EVINS其他文献

A EDEN EVINS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('A EDEN EVINS', 18)}}的其他基金

Research Supplement to Promote Diversity in Health-Related Research: Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
促进健康相关研究多样性的研究补充:伐尼克兰对青少年非吸烟者戒烟尼古丁的随机对照试验
  • 批准号:
    10878366
  • 财政年份:
    2021
  • 资助金额:
    $ 66.96万
  • 项目类别:
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain
慢性非癌性疼痛患者的医用大麻、疼痛和阿片类药物的使用
  • 批准号:
    10211907
  • 财政年份:
    2021
  • 资助金额:
    $ 66.96万
  • 项目类别:
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain
慢性非癌性疼痛患者的医用大麻、疼痛和阿片类药物的使用
  • 批准号:
    10641911
  • 财政年份:
    2021
  • 资助金额:
    $ 66.96万
  • 项目类别:
Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
伐尼克兰用于青少年非吸烟者戒烟尼古丁的随机对照试验
  • 批准号:
    10689064
  • 财政年份:
    2021
  • 资助金额:
    $ 66.96万
  • 项目类别:
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain
慢性非癌性疼痛患者的医用大麻、疼痛和阿片类药物的使用
  • 批准号:
    10491683
  • 财政年份:
    2021
  • 资助金额:
    $ 66.96万
  • 项目类别:
Administrative Supplement: Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
行政补充:伐尼克兰用于青少年非吸烟者戒烟尼古丁的随机对照试验
  • 批准号:
    10878378
  • 财政年份:
    2021
  • 资助金额:
    $ 66.96万
  • 项目类别:
Advancing a novel portable detection method for cannabis intoxication
推进一种新型便携式大麻中毒检测方法
  • 批准号:
    10145857
  • 财政年份:
    2017
  • 资助金额:
    $ 66.96万
  • 项目类别:
Career Development Program in Substance Use and Addiction Medicine
药物滥用和成瘾医学职业发展计划
  • 批准号:
    10215450
  • 财政年份:
    2017
  • 资助金额:
    $ 66.96万
  • 项目类别:
Career Development Program in Substance Use and Addiction Medicine
药物滥用和成瘾医学职业发展计划
  • 批准号:
    10675872
  • 财政年份:
    2017
  • 资助金额:
    $ 66.96万
  • 项目类别:
Advancing a novel portable detection method for cannabis intoxication
推进一种新型便携式大麻中毒检测方法
  • 批准号:
    9751264
  • 财政年份:
    2017
  • 资助金额:
    $ 66.96万
  • 项目类别:

相似海外基金

Enhancing Structural Competency in School-Based Health Centers to Address LGBTQ+ Adolescent Health Equity
增强校本健康中心的结构能力,以解决 LGBTQ 青少年健康公平问题
  • 批准号:
    10608426
  • 财政年份:
    2023
  • 资助金额:
    $ 66.96万
  • 项目类别:
Application and feasability of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care - a pilot study
简短的数字筛查工具的应用和可行性,以解决儿科医疗中父母和青少年烟草和电子烟的使用问题 - 一项试点研究
  • 批准号:
    486580
  • 财政年份:
    2022
  • 资助金额:
    $ 66.96万
  • 项目类别:
    Studentship Programs
Co-design of an intervention to address alcohol use among adolescent boys and young men in Tanzania
共同设计一项干预措施,解决坦桑尼亚青春期男孩和年轻男性的饮酒问题
  • 批准号:
    MR/V032380/1
  • 财政年份:
    2022
  • 资助金额:
    $ 66.96万
  • 项目类别:
    Research Grant
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
  • 批准号:
    MR/V005790/1
  • 财政年份:
    2021
  • 资助金额:
    $ 66.96万
  • 项目类别:
    Research Grant
Application of a brief digital screening tool to address parental and adolescent tobacco and electronic cigarette use in pediatric medical care
应用简短的数字筛查工具来解决儿科医疗中父母和青少年烟草和电子烟的使用问题
  • 批准号:
    455984
  • 财政年份:
    2021
  • 资助金额:
    $ 66.96万
  • 项目类别:
    Operating Grants
Complex intervention to optimise adolescent BMI pre-conception to address the double burden of malnutrition: A RCT in rural and urban South Africa
优化青少年孕前体重指数以解决营养不良的双重负担的复杂干预措施:南非农村和城市的随机对照试验
  • 批准号:
    MR/V005790/2
  • 财政年份:
    2021
  • 资助金额:
    $ 66.96万
  • 项目类别:
    Research Grant
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
  • 批准号:
    10057761
  • 财政年份:
    2020
  • 资助金额:
    $ 66.96万
  • 项目类别:
Development of the Cannabis Actions and Practices (CAP): A Parent-Focused Intervention to Address Adolescent Marijuana Use
大麻行动和实践 (CAP) 的发展:以家长为中心的干预措施,解决青少年大麻使用问题
  • 批准号:
    10213683
  • 财政年份:
    2020
  • 资助金额:
    $ 66.96万
  • 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
  • 批准号:
    9403567
  • 财政年份:
    2017
  • 资助金额:
    $ 66.96万
  • 项目类别:
Designing targeted interventions to address HIV vulnerabilities and improve clinical outcomes among conflict affected adolescent girls and young women under 25 in Northern Uganda
设计有针对性的干预措施,以解决乌干达北部受冲突影响的少女和 25 岁以下年轻妇女的艾滋病毒脆弱性并改善临床结果
  • 批准号:
    356145
  • 财政年份:
    2016
  • 资助金额:
    $ 66.96万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了